Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32732391

153 results
Filters applied: . Clear all
Page 1
High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
Clarke C, Prendecki M, Dhutia A, Ali MA, Sajjad H, Shivakumar O, Lightstone L, Kelleher P, Pickering MC, Thomas D, Charif R, Griffith M, McAdoo SP, Willicombe M. Clarke C, et al. J Am Soc Nephrol. 2020 Sep;31(9):1969-1975. doi: 10.1681/ASN.2020060827. Epub 2020 Jul 30. J Am Soc Nephrol. 2020. PMID: 32732391
Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, Adriano A, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Dittrich S, Emperador D, Hooft L, Leeflang MM, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Deeks JJ, et al. Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652. Cochrane Database Syst Rev. 2020. PMID: 32584464
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
Bryan A, Pepper G, Wener MH, Fink SL, Morishima C, Chaudhary A, Jerome KR, Mathias PC, Greninger AL. Bryan A, et al. J Clin Microbiol. 2020 Jul 23;58(8):e00941-20. doi: 10.1128/JCM.00941-20. Print 2020 Jul 23. J Clin Microbiol. 2020. PMID: 32381641 Free PMC article.
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S, Colavita F, Bordi L, Matusali G, Lapa D, Amendola A, Vairo F, Ippolito G, Capobianchi MR, Castilletti C; INMICovid-19 laboratory team. Meschi S, et al. J Clin Virol. 2020 Aug;129:104539. doi: 10.1016/j.jcv.2020.104539. Epub 2020 Jul 6. J Clin Virol. 2020. PMID: 32679298 Free PMC article.
SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T, Berghoff AS, Heller G, Haslacher H, Perkmann T, Strassl R, Berger JM, Puhr HC, Kreminger J, Moik F, Schubert L, Starzer AM, Steindl A, Winkler S, Preusser M, Tobudic S. Fuereder T, et al. ESMO Open. 2020 Sep;5(5):e000889. doi: 10.1136/esmoopen-2020-000889. ESMO Open. 2020. PMID: 32878898 Free PMC article.
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, Sanmartín JL, Fernández-García A, Cruz I, Fernández de Larrea N, Molina M, Rodríguez-Cabrera F, Martín M, Merino-Amador P, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R; ENE-COVID Study Group. Pollán M, et al. Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6. Lancet. 2020. PMID: 32645347 Free PMC article.
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
Self WH, Tenforde MW, Stubblefield WB, Feldstein LR, Steingrub JS, Shapiro NI, Ginde AA, Prekker ME, Brown SM, Peltan ID, Gong MN, Aboodi MS, Khan A, Exline MC, Files DC, Gibbs KW, Lindsell CJ, Rice TW, Jones ID, Halasa N, Talbot HK, Grijalva CG, Casey JD, Hager DN, Qadir N, Henning DJ, Coughlin MM, Schiffer J, Semenova V, Li H, Thornburg NJ, Patel MM; CDC COVID-19 Response Team; IVY Network. Self WH, et al. MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1221-1226. doi: 10.15585/mmwr.mm6935e2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32881855 Free PMC article.
High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
McDade TW, McNally EM, Zelikovich AS, D'Aquila R, Mustanski B, Miller A, Vaught LA, Reiser NL, Bogdanovic E, Fallon KS, Demonbreun AR. McDade TW, et al. PLoS One. 2020 Aug 14;15(8):e0237833. doi: 10.1371/journal.pone.0237833. eCollection 2020. PLoS One. 2020. PMID: 32797108 Free PMC article.
Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
Sapkal G, Shete-Aich A, Jain R, Yadav PD, Sarkale P, Lakra R, Baradkar S, Deshpande GR, Mali D, Tilekar BN, Majumdar T, Kaushal H, Gurav Y, Gupta N, Mohandas S, Deshpande K, Kaduskar O, Salve M, Patil S, Gaikwad S, Sugunan AP, Ashok M, Giri S, Shastri J, Abraham P, Gangakhedkar RR; $COVID Support Team: Pawar S., Patshute S., Salve V., Natarajan V., Marwah V., Malhotra B., Jain A., Sathe P., More R., Khedekar R., Suryawanshi D., Kalele K., Kumar A., Upadhyaya C.P., Waghmare A., Gawande P., Gopale S., Acharya M., Holeppanavar M., Thorat S., Chopade G., Vidhate S., Khutwad K., Phagiwala D., Bhanarkar S., Rakhe A., Salvi V., Dhaigude S., Ciyona. Sapkal G, et al. Indian J Med Res. 2020 May;151(5):444-449. doi: 10.4103/ijmr.IJMR_2232_20. Indian J Med Res. 2020. PMID: 32611915 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Stringhini S, et al. Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11. Lancet. 2020. PMID: 32534626 Free PMC article.
153 results
Jump to page
Feedback